205 related articles for article (PubMed ID: 19435910)
1. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
[TBL] [Abstract][Full Text] [Related]
2. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Li D; Yuan Y; Meng C; Lin Z; Zhao M; Shi L; Li M; Ye D; Cai Y; He X; Ye H; Zhou S; Zhou H; Gao S
Clin Epigenetics; 2024 Mar; 16(1):48. PubMed ID: 38528641
[TBL] [Abstract][Full Text] [Related]
3.
Moubarak RS; Koetz-Ploch L; Mullokandov G; Gaziel A; de Pablos-Aragoneses A; Argibay D; Kleffman K; Sokolova E; Berwick M; Thomas NE; Osman I; Brown BD; Hernando E
Front Oncol; 2022; 12():852952. PubMed ID: 35480113
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics of acute lymphocytic leukemia.
Garcia-Manero G; Yang H; Kuang SQ; O'Brien S; Thomas D; Kantarjian H
Semin Hematol; 2009 Jan; 46(1):24-32. PubMed ID: 19100365
[TBL] [Abstract][Full Text] [Related]
5. CDK6: an attractive therapeutic target for T-ALL/LBL.
Li W; Hu JK; Hu MG
Expert Opin Ther Targets; 2023; 27(11):1087-1096. PubMed ID: 37975616
[TBL] [Abstract][Full Text] [Related]
6. Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
Zhu YD; Wang L; Sun C; Fan L; Zhu DX; Fang C; Wang YH; Zou ZJ; Zhang SJ; Li JY; Xu W
Med Oncol; 2012 Dec; 29(4):2323-31. PubMed ID: 22209839
[TBL] [Abstract][Full Text] [Related]
7. miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic review.
Gutierrez-Camino A; Garcia-Obregon S; Lopez-Lopez E; Astigarraga I; Garcia-Orad A
Epigenomics; 2020 Jan; 12(1):69-80. PubMed ID: 31833405
[TBL] [Abstract][Full Text] [Related]
8. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibitors.
Kubeczko M; Tudrej P; Tyszkiewicz T; Krzywon A; Oczko-Wojciechowska M; JarzĄb M
Oncol Lett; 2024 Apr; 27(4):181. PubMed ID: 38464342
[TBL] [Abstract][Full Text] [Related]
10. A semi-supervised approach for the integration of multi-omics data based on transformer multi-head self-attention mechanism and graph convolutional networks.
Wang J; Liao N; Du X; Chen Q; Wei B
BMC Genomics; 2024 Jan; 25(1):86. PubMed ID: 38254021
[TBL] [Abstract][Full Text] [Related]
11. The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms.
Barrios-Palacios D; Organista-Nava J; Balandrán JC; Alarcón-Romero LDC; Zubillaga-Guerrero MI; Illades-Aguiar B; Rivas-Alarcón AA; Diaz-Lucas JJ; Gómez-Gómez Y; Leyva-Vázquez MA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203290
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles.
Mondal D; Shinde S; Paul S; Thakur S; Velu G; Tiwari AK; Dixit V; Amit A; Vishvakarma NK; Shukla D
Front Oncol; 2023; 13():1230273. PubMed ID: 37637043
[TBL] [Abstract][Full Text] [Related]
13. Can Dietary Actives Affect miRNAs and Alter the Course or Prevent Colorectal Cancer?
Prendecka-Wróbel M; Pigoń-Zając D; Sondej D; Grzywna K; Kamińska K; Szuta M; Małecka-Massalska T
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373289
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition.
Hu Q; Huang T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240281
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between miRNAs and DNA Methylation in Cancer.
Saviana M; Le P; Micalo L; Del Valle-Morales D; Romano G; Acunzo M; Li H; Nana-Sinkam P
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239435
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.
Sevcikova A; Fridrichova I; Nikolaieva N; Kalinkova L; Omelka R; Martiniakova M; Ciernikova S
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174123
[TBL] [Abstract][Full Text] [Related]
17. Potential involvement of circulating extracellular vesicles and particles on exercise effects in malignancies.
Siqueira IR; Batabyal RA; Freishtat R; Cechinel LR
Front Endocrinol (Lausanne); 2023; 14():1121390. PubMed ID: 36936170
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia.
Drożak P; Bryliński Ł; Zawitkowska J
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358802
[TBL] [Abstract][Full Text] [Related]
19. The Role of DNA Methylation and DNA Methyltransferases in Cancer.
Weisenberger DJ; Lakshminarasimhan R; Liang G
Adv Exp Med Biol; 2022; 1389():317-348. PubMed ID: 36350516
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
